<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><label>Table 2.</label><caption><title>Characteristic oscillatory changes during dexmedetomidine-induced altered behavioral states.</title></caption><table frame="hsides" rules="groups"><thead><tr><th>Behavioral state</th><th>Slow-Delta</th><th>Alpha</th><th>Beta</th><th>Spindle activity</th><th/></tr></thead><tbody><tr><td>Wakefulness</td><td>minimal</td><td>absent</td><td>high</td><td>absent</td><td rowspan="5"><xref ref-type="fig" rid="fig2">Figure 2B,C,E,F</xref> <break/><xref ref-type="fig" rid="fig4">Figure 4B</xref></td></tr><tr><td>LOC</td><td>high with delay</td><td>transiently high</td><td>minimal</td><td>high</td></tr><tr><td>Unresponsiveness</td><td>high</td><td>low</td><td>absent</td><td>high</td></tr><tr><td>ROC</td><td>minimal*</td><td>high</td><td>absent</td><td>high</td></tr><tr><td>ROPAP</td><td>minimal</td><td>minimal</td><td>high</td><td>minimal</td></tr><tr><td>Arousal by external stimuli after LOC during dexmedetomidine infusion</td><td>minimal</td><td>transiently high</td><td>absent</td><td>NA</td><td><xref ref-type="fig" rid="fig2">Figure 2H</xref></td></tr><tr><td>Reversal by &#945;2-adrenergic antagonist during dexmedetomidine infusion</td><td>minimal</td><td>absent</td><td>high</td><td>absent</td><td><xref ref-type="fig" rid="fig5">Figure 5B,C,E,F,G</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Note: The characteristic changes of the frequency band power and spindle activity are summarized for each behavioral endpoint. *The slow-delta power was diminished at ROC, but frequently reappeared through early recovery until ROPAP.</p></fn></table-wrap-foot></table-wrap>